'GLP-1-branded skincare' and other major dermatology trends to watch through 2027

By Alpana Mohta, MD, DNB, FEADV, FIADVL, IFAADFact-checked by Davi ShermanPublished May 29, 2026

Skincare in 2026 is no longer about one look. Glass skin, slugging, and 10-step routines still show up in search and social feeds, but the larger shift is toward skincare marketed around barrier repair, dermatology literacy, preventive routines, and aesthetic outcomes.

The global skincare market has been projected to value $208.80 billion by the end of 2026.^[]

For physicians, this points to a practical clinical reality: More patients are treating skincare as healthcare, self-care, and aesthetic medicine. Rekha Kumar, board-certified dermatologist and founder of VR Skin Clinic, says, “Glass skin is no longer the whole story. The 2026 skincare market is split between barrier repair and medicalized biologic claims.”

The healthy trend

The good trend is “boring” care returning to center stage: cleanser, moisturizer, sunscreen, retinoid when appropriate, fewer actives, and barrier repair after years of exfoliant stacking.

Dr. Kumar says to frame glass skin as hydration-focused rather than perfection-focused, with simple routines and sunscreen as core advice.

The higher-risk trends

Exosomes

The higher-risk trend is biologic skincare.

Exosomes are being marketed for aging, redness, pigmentation, hair loss, acne scarring, and post-procedure healing. According to Dr. Kumar, exosomes are “trending hot” right now in the beauty industry. She says the inclusion of exosomes in skincare lets brands position their products as advanced, science-forward, and regenerative.

But she also cautions physicians and consumers to separate promise from proof, as regulation still trails the marketing. “Although the results of exosomes are promising, [the] FDA has not approved exosome products for any use so far,” she adds.

The evidence base is early. A 2025 dermatology review described plausible mechanisms for exosomes, including cell-signaling and tissue-repair pathways, while noting that evidence is mostly preclinical or in the early phase, with inconsistent methods, variable sources, limited long-term trials, and no FDA-approved cosmetic dermatology exosome product.^[]

PDRN and polynucleotides

PDRN and polynucleotides are also moving from aesthetic clinics into consumer skincare products. Reviews in 2024 and 2025 describe potential effects on skin texture, hydration, wrinkles, hyperpigmentation, barrier dysfunction, and regeneration.^[]

But what about topical skincare infused with PDRN? “Topical claims require caution. Molecular size, formulation stability, penetration, sourcing, and allergy risk matter. Patients often hear ‘salmon DNA’ and assume a biologic treatment is safer than retinoids, lasers, or injectables. The evidence does not support that assumption across products,” Dr. Kumar clarifies.

Post-GLP-1-related aesthetics

GLP-1-related aesthetics is moving into skincare. Rapid or substantial weight loss often makes patients more aware of facial volume loss, neck laxity, crepey texture, body skin laxity, acne flares, and hair shedding. McKinsey & Company reported that 63% of GLP-1 users interested in facial aesthetic products or procedures were new to the category, and providers were already seeing demand around facial fullness, skin laxity, and skin quality.^[]

“I am beginning to see more and more post-GLP-1-induced weight loss patients asking about skincare and aesthetic procedures to correct skin laxity, volume loss, acne flares, and hair shedding,” Dr. Kumar adds.

The market is responding with GLP-1-branded skincare. For example, Image Skincare launched VOL.U.LIFT GLP-1 4D Skin Rebound Complex, positioned around deflation, deep wrinkles, dehydration, and density loss after medication-driven or rapid weight loss. Dr. Few Skincare launched DermaReverse for GLP-1 users. A small split-face, placebo-controlled clinical trial reported improvements in hydration, roughness, pigmentation, visible pores, and static wrinkles after 6 weeks.^[]

Still, GLP-1 skincare is mostly familiar ingredients in new packaging. “Such formulas often rely on retinoid derivatives, peptides, hyaluronic acid, bakuchiol, antioxidants, and barrier-supporting hydrators. They may improve hydration, texture, and perceived firmness, but they will not replace lost facial fat, correct significant laxity, or rebuild facial structure. Patients need to know that before spending heavily on GLP-1-branded skincare,” Dr. Kumar says.

SHARE THIS ARTICLE